Logo image of ACMR

ACM RESEARCH INC-CLASS A (ACMR) Stock Fundamental Analysis

NASDAQ:ACMR - Nasdaq - US00108J1097 - Common Stock - Currency: USD

24.78  -0.29 (-1.16%)

Fundamental Rating

5

Taking everything into account, ACMR scores 5 out of 10 in our fundamental rating. ACMR was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. ACMR has only an average score on both its financial health and profitability. ACMR is growing strongly while it also seems undervalued. This is an interesting combination


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

ACMR had positive earnings in the past year.
ACMR had a positive operating cash flow in the past year.
ACMR had positive earnings in each of the past 5 years.
In the past 5 years ACMR reported 4 times negative operating cash flow.
ACMR Yearly Net Income VS EBIT VS OCF VS FCFACMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

ACMR's Return On Assets of 5.50% is fine compared to the rest of the industry. ACMR outperforms 70.00% of its industry peers.
ACMR has a better Return On Equity (11.21%) than 74.55% of its industry peers.
With a decent Return On Invested Capital value of 9.27%, ACMR is doing good in the industry, outperforming 79.09% of the companies in the same industry.
ACMR had an Average Return On Invested Capital over the past 3 years of 7.59%. This is below the industry average of 10.86%.
The 3 year average ROIC (7.59%) for ACMR is below the current ROIC(9.27%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.5%
ROE 11.21%
ROIC 9.27%
ROA(3y)4.65%
ROA(5y)4.61%
ROE(3y)9.12%
ROE(5y)9.25%
ROIC(3y)7.59%
ROIC(5y)6.61%
ACMR Yearly ROA, ROE, ROICACMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400 500

1.3 Margins

ACMR has a better Profit Margin (13.26%) than 71.82% of its industry peers.
ACMR's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 18.94%, ACMR is in the better half of the industry, outperforming 77.27% of the companies in the same industry.
ACMR's Operating Margin has improved in the last couple of years.
ACMR's Gross Margin of 49.23% is in line compared to the rest of the industry. ACMR outperforms 60.00% of its industry peers.
In the last couple of years the Gross Margin of ACMR has remained more or less at the same level.
Industry RankSector Rank
OM 18.94%
PM (TTM) 13.26%
GM 49.23%
OM growth 3Y9.03%
OM growth 5Y3.12%
PM growth 3Y-3.07%
PM growth 5Y-5.5%
GM growth 3Y4.22%
GM growth 5Y1.2%
ACMR Yearly Profit, Operating, Gross MarginsACMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACMR is destroying value.
The number of shares outstanding for ACMR has been increased compared to 1 year ago.
The number of shares outstanding for ACMR has been increased compared to 5 years ago.
The debt/assets ratio for ACMR is higher compared to a year ago.
ACMR Yearly Shares OutstandingACMR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ACMR Yearly Total Debt VS Total AssetsACMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

ACMR has an Altman-Z score of 2.45. This is not the best score and indicates that ACMR is in the grey zone with still only limited risk for bankruptcy at the moment.
ACMR has a Altman-Z score of 2.45. This is comparable to the rest of the industry: ACMR outperforms 40.91% of its industry peers.
The Debt to FCF ratio of ACMR is 2.52, which is a good value as it means it would take ACMR, 2.52 years of fcf income to pay off all of its debts.
ACMR's Debt to FCF ratio of 2.52 is fine compared to the rest of the industry. ACMR outperforms 65.45% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that ACMR is not too dependend on debt financing.
ACMR's Debt to Equity ratio of 0.17 is in line compared to the rest of the industry. ACMR outperforms 48.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 2.52
Altman-Z 2.45
ROIC/WACC0.82
WACC11.28%
ACMR Yearly LT Debt VS Equity VS FCFACMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

ACMR has a Current Ratio of 2.46. This indicates that ACMR is financially healthy and has no problem in meeting its short term obligations.
ACMR's Current ratio of 2.46 is on the low side compared to the rest of the industry. ACMR is outperformed by 62.73% of its industry peers.
ACMR has a Quick Ratio of 1.49. This is a normal value and indicates that ACMR is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ACMR (1.49) is worse than 72.73% of its industry peers.
Industry RankSector Rank
Current Ratio 2.46
Quick Ratio 1.49
ACMR Yearly Current Assets VS Current LiabilitesACMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

7

3. Growth

3.1 Past

ACMR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.80%.
Measured over the past years, ACMR shows a very strong growth in Earnings Per Share. The EPS has been growing by 42.35% on average per year.
ACMR shows a strong growth in Revenue. In the last year, the Revenue has grown by 40.23%.
ACMR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 48.72% yearly.
EPS 1Y (TTM)5.8%
EPS 3Y52.55%
EPS 5Y42.35%
EPS Q2Q%-1.82%
Revenue 1Y (TTM)40.23%
Revenue growth 3Y44.39%
Revenue growth 5Y48.72%
Sales Q2Q%6.37%

3.2 Future

The Earnings Per Share is expected to grow by 3.55% on average over the next years.
Based on estimates for the next years, ACMR will show a quite strong growth in Revenue. The Revenue will grow by 16.65% on average per year.
EPS Next Y1.89%
EPS Next 2Y3.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.12%
Revenue Next 2Y18.76%
Revenue Next 3Y18.8%
Revenue Next 5Y16.65%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ACMR Yearly Revenue VS EstimatesACMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
ACMR Yearly EPS VS EstimatesACMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5 2

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.32, the valuation of ACMR can be described as very reasonable.
Based on the Price/Earnings ratio, ACMR is valued cheaply inside the industry as 96.36% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.85. ACMR is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 10.22, the valuation of ACMR can be described as reasonable.
Based on the Price/Forward Earnings ratio, ACMR is valued cheaper than 96.36% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.98. ACMR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.32
Fwd PE 10.22
ACMR Price Earnings VS Forward Price EarningsACMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

94.55% of the companies in the same industry are more expensive than ACMR, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACMR indicates a rather cheap valuation: ACMR is cheaper than 86.36% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.52
EV/EBITDA 7.85
ACMR Per share dataACMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of ACMR may justify a higher PE ratio.
PEG (NY)6
PEG (5Y)0.27
EPS Next 2Y3.55%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ACMR!.
Industry RankSector Rank
Dividend Yield N/A

ACM RESEARCH INC-CLASS A

NASDAQ:ACMR (8/20/2025, 12:45:19 PM)

24.78

-0.29 (-1.16%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners69.39%
Inst Owner Change2.66%
Ins Owners5.53%
Ins Owner Change0.95%
Market Cap1.58B
Analysts81.43
Price Target36.3 (46.49%)
Short Float %6.3%
Short Ratio3.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)32.31%
Min EPS beat(2)22.75%
Max EPS beat(2)41.87%
EPS beat(4)4
Avg EPS beat(4)46.12%
Min EPS beat(4)22.75%
Max EPS beat(4)65.81%
EPS beat(8)8
Avg EPS beat(8)93.35%
EPS beat(12)12
Avg EPS beat(12)967.56%
EPS beat(16)14
Avg EPS beat(16)712.87%
Revenue beat(2)2
Avg Revenue beat(2)7.3%
Min Revenue beat(2)2.19%
Max Revenue beat(2)12.4%
Revenue beat(4)4
Avg Revenue beat(4)10.24%
Min Revenue beat(4)2.19%
Max Revenue beat(4)21.75%
Revenue beat(8)7
Avg Revenue beat(8)9.33%
Revenue beat(12)11
Avg Revenue beat(12)11.86%
Revenue beat(16)12
Avg Revenue beat(16)7.58%
PT rev (1m)1.81%
PT rev (3m)-0.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.87%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.94%
Revenue NY rev (1m)0.4%
Revenue NY rev (3m)-0.39%
Valuation
Industry RankSector Rank
PE 11.32
Fwd PE 10.22
P/S 1.97
P/FCF 17.52
P/OCF 9.45
P/B 1.67
P/tB 1.67
EV/EBITDA 7.85
EPS(TTM)2.19
EY8.84%
EPS(NY)2.42
Fwd EY9.78%
FCF(TTM)1.41
FCFY5.71%
OCF(TTM)2.62
OCFY10.58%
SpS12.56
BVpS14.86
TBVpS14.82
PEG (NY)6
PEG (5Y)0.27
Profitability
Industry RankSector Rank
ROA 5.5%
ROE 11.21%
ROCE 11.64%
ROIC 9.27%
ROICexc 14.73%
ROICexgc 14.78%
OM 18.94%
PM (TTM) 13.26%
GM 49.23%
FCFM 11.26%
ROA(3y)4.65%
ROA(5y)4.61%
ROE(3y)9.12%
ROE(5y)9.25%
ROIC(3y)7.59%
ROIC(5y)6.61%
ROICexc(3y)11.47%
ROICexc(5y)11.39%
ROICexgc(3y)11.51%
ROICexgc(5y)11.42%
ROCE(3y)9.71%
ROCE(5y)8.55%
ROICexcg growth 3Y8.64%
ROICexcg growth 5Y4.84%
ROICexc growth 3Y8.55%
ROICexc growth 5Y4.8%
OM growth 3Y9.03%
OM growth 5Y3.12%
PM growth 3Y-3.07%
PM growth 5Y-5.5%
GM growth 3Y4.22%
GM growth 5Y1.2%
F-Score5
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 2.52
Debt/EBITDA 0.98
Cap/Depr 736.33%
Cap/Sales 9.6%
Interest Coverage 30.83
Cash Conversion 103.06%
Profit Quality 84.93%
Current Ratio 2.46
Quick Ratio 1.49
Altman-Z 2.45
F-Score5
WACC11.28%
ROIC/WACC0.82
Cap/Depr(3y)1126.77%
Cap/Depr(5y)1047%
Cap/Sales(3y)15.44%
Cap/Sales(5y)11.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.8%
EPS 3Y52.55%
EPS 5Y42.35%
EPS Q2Q%-1.82%
EPS Next Y1.89%
EPS Next 2Y3.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)40.23%
Revenue growth 3Y44.39%
Revenue growth 5Y48.72%
Sales Q2Q%6.37%
Revenue Next Year22.12%
Revenue Next 2Y18.76%
Revenue Next 3Y18.8%
Revenue Next 5Y16.65%
EBIT growth 1Y35.73%
EBIT growth 3Y57.43%
EBIT growth 5Y53.36%
EBIT Next Year11.61%
EBIT Next 3Y13.48%
EBIT Next 5Y11.92%
FCF growth 1Y153.47%
FCF growth 3YN/A
FCF growth 5Y51.73%
OCF growth 1Y357.71%
OCF growth 3YN/A
OCF growth 5Y74.58%